FR2889949A1 - Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus - Google Patents
Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus Download PDFInfo
- Publication number
- FR2889949A1 FR2889949A1 FR0508796A FR0508796A FR2889949A1 FR 2889949 A1 FR2889949 A1 FR 2889949A1 FR 0508796 A FR0508796 A FR 0508796A FR 0508796 A FR0508796 A FR 0508796A FR 2889949 A1 FR2889949 A1 FR 2889949A1
- Authority
- FR
- France
- Prior art keywords
- cosmetic
- pyrus
- dermo
- skin
- plant extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 235000011430 Malus pumila Nutrition 0.000 title abstract description 14
- 235000015103 Malus silvestris Nutrition 0.000 title abstract description 14
- 244000141359 Malus pumila Species 0.000 title abstract description 12
- 239000012676 herbal extract Substances 0.000 title abstract 4
- 102000004363 Aquaporin 3 Human genes 0.000 claims abstract description 21
- 108090000991 Aquaporin 3 Proteins 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 230000000694 effects Effects 0.000 claims abstract description 17
- 210000003491 skin Anatomy 0.000 claims abstract description 15
- 210000002615 epidermis Anatomy 0.000 claims description 21
- 239000000419 plant extract Substances 0.000 claims description 16
- 230000036571 hydration Effects 0.000 claims description 13
- 238000006703 hydration reaction Methods 0.000 claims description 13
- 241000220324 Pyrus Species 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 235000010356 sorbitol Nutrition 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- 229930003935 flavonoid Natural products 0.000 claims description 3
- 235000017173 flavonoids Nutrition 0.000 claims description 3
- 150000002215 flavonoids Chemical class 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 229930013035 isoflavonoid derivative Natural products 0.000 claims description 3
- 150000003817 isoflavonoid derivatives Chemical class 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 229940024606 amino acid Drugs 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 1
- 210000002510 keratinocyte Anatomy 0.000 abstract description 9
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 238000004166 bioassay Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 210000002850 nasal mucosa Anatomy 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 18
- 102000010637 Aquaporins Human genes 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 108010063290 Aquaporins Proteins 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- OIALAIQRYISUEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]e Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO OIALAIQRYISUEV-UHFFFAOYSA-N 0.000 description 2
- 108090001004 Aquaporin 1 Proteins 0.000 description 2
- 102000004888 Aquaporin 1 Human genes 0.000 description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000002867 manganese chloride Nutrition 0.000 description 2
- 239000011565 manganese chloride Substances 0.000 description 2
- 229940099607 manganese chloride Drugs 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000003359 percent control normalization Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- LEVVMZZBTOYKSC-UHFFFAOYSA-N 1-amino-4-hydroxybutane-2-sulfonic acid Chemical compound NCC(S(O)(=O)=O)CCO LEVVMZZBTOYKSC-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 102100029406 Aquaporin-7 Human genes 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 101000771402 Homo sapiens Aquaporin-7 Proteins 0.000 description 1
- 101000771413 Homo sapiens Aquaporin-9 Proteins 0.000 description 1
- 241000138806 Impages Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 244000081841 Malus domestica Species 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 238000001190 Q-PCR Methods 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229960001983 magnesium aspartate Drugs 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- CRSJYWPXKKSOCQ-CBAPHJFVSA-L magnesium;(2s)-2-aminobutanedioate;hydron;tetrahydrate Chemical compound O.O.O.O.[Mg+2].[O-]C(=O)[C@@H](N)CC(O)=O.[O-]C(=O)[C@@H](N)CC(O)=O CRSJYWPXKKSOCQ-CBAPHJFVSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- VYGQUTWHTHXGQB-FFHKNEKCSA-N retinyl palmitate Natural products CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229930188627 soysaponin Natural products 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0508796A FR2889949B1 (fr) | 2005-08-26 | 2005-08-26 | Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0508796A FR2889949B1 (fr) | 2005-08-26 | 2005-08-26 | Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2889949A1 true FR2889949A1 (fr) | 2007-03-02 |
FR2889949B1 FR2889949B1 (fr) | 2014-01-10 |
Family
ID=36717045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0508796A Active FR2889949B1 (fr) | 2005-08-26 | 2005-08-26 | Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2889949B1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2925332A1 (fr) * | 2007-12-21 | 2009-06-26 | Vincience Sa | Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines |
WO2012130771A1 (fr) | 2011-03-25 | 2012-10-04 | Lipotec S.A. | Peptides utiles dans le traitement et/ou le soin de la peau et/ou des membranes muqueuses et leur utilisation dans des compositions cosmétiques ou pharmaceutiques |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5344639A (en) * | 1976-10-04 | 1978-04-21 | Kouichi Ogawa | Cosmetics |
JPH1171294A (ja) * | 1997-08-29 | 1999-03-16 | Pias Arise Kk | コラゲナーゼ阻害剤 |
JP2000344655A (ja) * | 1999-06-01 | 2000-12-12 | Fancl Corp | 皮膚化粧料 |
JP2002363025A (ja) * | 2001-06-01 | 2002-12-18 | Nippon Zettoc Co Ltd | 皮膚外用剤及びその製造方法 |
JP2003160433A (ja) * | 2001-11-27 | 2003-06-03 | Shiseido Co Ltd | 抗老化用皮膚外用剤 |
WO2003053394A2 (fr) * | 2001-12-21 | 2003-07-03 | Henkel Kommanditgesellschaft Auf Aktien | Utilisations d'extraits de pepins de pomme dans des pre parations cosmetiques ou pharmaceutiques |
JP2004131500A (ja) * | 2002-09-19 | 2004-04-30 | Fancl Corp | 皮膚老化防止剤又は改善剤 |
JP3529811B2 (ja) * | 1993-06-30 | 2004-05-24 | 三省製薬株式会社 | 皮膚外用剤 |
EP1428520A2 (fr) * | 2002-12-10 | 2004-06-16 | Henkel Kommanditgesellschaft auf Aktien | Inhibiteurs de la lipase dans des produits déodorants et antitranspirants |
WO2006018198A1 (fr) * | 2004-08-13 | 2006-02-23 | Henkel Kommanditgesellschaft Auf Aktien | Compositions cosmetiques et dermatologiques a base de (2-hydroxyethyl)uree |
EP1640041A2 (fr) * | 2004-09-24 | 2006-03-29 | Henkel Kommanditgesellschaft auf Aktien | composition cosmétique ou dermatologique pour le traitement du vieillissement de la peau ou pour le traitement de la peau endommagée par la lumière |
EP1671673A1 (fr) * | 2004-12-20 | 2006-06-21 | Henkel Kommanditgesellschaft auf Aktien | Composition contenant des pigments sous forme d'émulsion eau-dans-huile de silicone pour ameliorer l'apparence de la peau |
-
2005
- 2005-08-26 FR FR0508796A patent/FR2889949B1/fr active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5344639A (en) * | 1976-10-04 | 1978-04-21 | Kouichi Ogawa | Cosmetics |
JP3529811B2 (ja) * | 1993-06-30 | 2004-05-24 | 三省製薬株式会社 | 皮膚外用剤 |
JPH1171294A (ja) * | 1997-08-29 | 1999-03-16 | Pias Arise Kk | コラゲナーゼ阻害剤 |
JP2000344655A (ja) * | 1999-06-01 | 2000-12-12 | Fancl Corp | 皮膚化粧料 |
JP2002363025A (ja) * | 2001-06-01 | 2002-12-18 | Nippon Zettoc Co Ltd | 皮膚外用剤及びその製造方法 |
JP2003160433A (ja) * | 2001-11-27 | 2003-06-03 | Shiseido Co Ltd | 抗老化用皮膚外用剤 |
WO2003053394A2 (fr) * | 2001-12-21 | 2003-07-03 | Henkel Kommanditgesellschaft Auf Aktien | Utilisations d'extraits de pepins de pomme dans des pre parations cosmetiques ou pharmaceutiques |
JP2004131500A (ja) * | 2002-09-19 | 2004-04-30 | Fancl Corp | 皮膚老化防止剤又は改善剤 |
EP1428520A2 (fr) * | 2002-12-10 | 2004-06-16 | Henkel Kommanditgesellschaft auf Aktien | Inhibiteurs de la lipase dans des produits déodorants et antitranspirants |
WO2006018198A1 (fr) * | 2004-08-13 | 2006-02-23 | Henkel Kommanditgesellschaft Auf Aktien | Compositions cosmetiques et dermatologiques a base de (2-hydroxyethyl)uree |
EP1640041A2 (fr) * | 2004-09-24 | 2006-03-29 | Henkel Kommanditgesellschaft auf Aktien | composition cosmétique ou dermatologique pour le traitement du vieillissement de la peau ou pour le traitement de la peau endommagée par la lumière |
EP1671673A1 (fr) * | 2004-12-20 | 2006-06-21 | Henkel Kommanditgesellschaft auf Aktien | Composition contenant des pigments sous forme d'émulsion eau-dans-huile de silicone pour ameliorer l'apparence de la peau |
Non-Patent Citations (12)
Title |
---|
ANONYMOUS: "Guinot Time Release Youth Boost Eyes", INTERNET ARTICLE, 15 February 2005 (2005-02-15), XP002393890, Retrieved from the Internet <URL:http://web.archive.org/web/20050215074047/http://skin-one.com/gutyreyloboey.html> [retrieved on 20060807] * |
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 31 August 1999 (1999-08-31), CHIGARINA K M ET AL: "Night nutrient cream", XP002250830, retrieved from STN Database accession no. 2001:875796 * |
DATABASE EPODOC EUROPEAN PATENT OFFICE, THE HAGUE, NL; 12 December 2000 (2000-12-12), XP002396581 * |
DATABASE EPODOC EUROPEAN PATENT OFFICE, THE HAGUE, NL; 30 April 2004 (2004-04-30), XP002396580 * |
DATABASE WPI Section Ch Week 197822, Derwent World Patents Index; Class D21, AN 1978-39536A, XP002250831, "Cosmetics contg. apple extract - comprising apple alcohol and its fatty acid ester(s)" * |
DATABASE WPI Section Ch Week 199921, Derwent World Patents Index; Class B04, AN 1999-248450, XP002250832, "New collagenase inhibitor comprising apple and/or grape seed extracts useful for preventing depletion of skin collagen" * |
DATABASE WPI Section Ch Week 200338, Derwent World Patents Index; Class B05, AN 2003-397395, XP002396586 * |
DATABASE WPI Section Ch Week 200377, Derwent World Patents Index; Class B04, AN 2003-818769, XP002396588 * |
DATABASE WPI Section Ch Week 200433, Derwent World Patents Index; Class B02, AN 2004-352908 * |
DATABASE WPI Section Ch Week 200434, Derwent World Patents Index; Class A96, AN 1995-093751, XP002396587 * |
IMPAG: "Pinboard", IMPAG NEWS, October 2002 (2002-10-01), XP002393892, Retrieved from the Internet <URL:http://www.impag.de/german/kosmetik/z12pin.htm> [retrieved on 20060807] * |
IMPAG: "The Power of the Apple", IMPAG NEWS, no. 8, January 2001 (2001-01-01), XP002393891, Retrieved from the Internet <URL:http://www.impag.de/english/kosmetik/z8apfel.htm> [retrieved on 20060807] * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2925332A1 (fr) * | 2007-12-21 | 2009-06-26 | Vincience Sa | Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines |
WO2012130771A1 (fr) | 2011-03-25 | 2012-10-04 | Lipotec S.A. | Peptides utiles dans le traitement et/ou le soin de la peau et/ou des membranes muqueuses et leur utilisation dans des compositions cosmétiques ou pharmaceutiques |
US9067967B2 (en) | 2011-03-25 | 2015-06-30 | Lipotec, S.A. | Peptides useful in the treatment and care of the skin and mucous membranes and their use in cosmetic or pharmaceutical compositions |
Also Published As
Publication number | Publication date |
---|---|
FR2889949B1 (fr) | 2014-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2953611B1 (fr) | Utilisation d'une composition comprenant un perséose d'avocat dans la protection des cellules souches épidermiques | |
JP6846422B2 (ja) | Palmaria palmataとジャスミンとの相乗作用的抽出物、それを含む組成物およびそれらの使用 | |
EP3280497B1 (fr) | Extrait hydro-alcoolique de schinus molle, compositions cosmetiques le comprenant et leurs utilisations cosmetiques | |
EP1928447A2 (fr) | Extrait de vanilla planifolia, son procede d' obtention, et composition cosmetique ou dermatologique le contenant | |
FR2977491A1 (fr) | Composition cosmetique comprenant un melange de miels | |
WO2007107856A1 (fr) | Huile de magnolia champaca, son procede de preparation et les compositions la contenant | |
FR3043329A1 (fr) | Composition cosmetique ou dermatologique et son utilisation | |
EP2763652B1 (fr) | Utilisation de glucanes obtenus a partir de prunus persica comme agent cosmetique anti-age | |
KR20210107724A (ko) | 로즈우드 추출물 | |
WO2019069007A1 (fr) | Procédé d'utilisation d'un inhibiteur de let-7b en cosmétique et/ou en nutraceutique | |
FR2889949A1 (fr) | Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus | |
FR3031458B1 (fr) | Extraits de salade, compositions et utilisations | |
FR2971711A1 (fr) | Composition cosmetique comprenant un extrait de petit epeautre en tant qu'agent activateur de la synthese des proteines de la matrice extracellulaire | |
FR3076461A1 (fr) | Composition cosmétique de prévention active des signes de l’âge. | |
FR3018448A1 (fr) | Principe actif obtenu a partir de l'algue hypnea musciformis et utilisations cosmetiques | |
EP1837392A1 (fr) | Huile de magnolia champaca, son procédé d'obtention, et compositions la contenant | |
FR3072289A1 (fr) | Composition cosmetique de prevention active des signes de l'age | |
FR3018685B1 (fr) | Applications cosmetiques et pharmaceutiques de la salicaire | |
WO2022208005A1 (fr) | Composition cosmetique comprenant au moins un extrait de bouleau et au moins un extrait de bourgeon de hetre | |
EP3763355A1 (fr) | Composition comprenant des polyphénols de graines de passiflore, des peptides d'avocat et un extrait d'hamamélis et utilisation pour traiter et/ou prévenir les vergetures | |
WO2021209593A1 (fr) | Principe actif comprenant un extrait d'écorce de fruit immature de punica granatum et utilisations pour prevenir et/ou lutter contre l'acne | |
FR3097127A1 (fr) | Procédé d’utilisation d’un inhibiteur de Let-7b en cosmétique et/ou en nutraceutique | |
WO2009002208A1 (fr) | Produit cosmétique microbiotique à base de collagénase | |
FR3042415A1 (fr) | Utilisation d'un extrait de reglisse (glycyrrhizza glabra l.) pour une action d'hydratation de la peau, de ses annexes ou des muqueuses | |
FR3042414A1 (fr) | Utilisation d'un extrait de reglisse (glycyrrhizza glabra l.) pour une action anti-age sur la peau, ses annexes ou les muqueuses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |
|
PLFP | Fee payment |
Year of fee payment: 19 |
|
AU | Other action affecting the ownership or exploitation of an industrial property right |
Effective date: 20231016 |
|
CL | Concession to grant licences |
Name of requester: NAOS, FR Effective date: 20231016 Name of requester: NAOS INSTITUTE OF LIFE SCIENCE, FR Effective date: 20231016 |